Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor

José A. Esté; Cecilia Cabrera; De Clercq Erik; Sofie Struyf; Jo Van Damme; Gary Bridger; Renato T. Skerlj; Michael J. Abrams; Geoffrey Henson; Arantxa Gutiérrez; Bonaventura Clotet; Dominique Schols

doi:10.1124/mol.55.1.67

Back

Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor

Article 1999 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1999

Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor

José A. Esté, Cecilia Cabrera, De Clercq Erik, Sofie Struyf, Jo Van Damme, Gary Bridger, Renato T. Skerlj, Michael J. Abrams, Geoffrey Henson, Arantxa Gutiérrez, Bonaventura Clotet, Dominique Schols

Article1998

Determinants for Sensitivity of Human Immunodeficiency Virus Coreceptor CXCR4 to the Bicyclam AMD3100

Béatrice Labrosse, Anne Brelot, Nikolaus Heveker, Nathalie Sol‐Foulon, Dominique Schols, De Clercq Erik, Marc Alizon

Article1999

Bicyclams, Selective Antagonists of the Human Chemokine Receptor CXCR4, Potently Inhibit Feline Immunodeficiency Virus Replication

Herman Egberink, De Clercq Erik, Arno L. W. van Vliet, Jan Balzarini, Gary Bridger, Geoffrey Henson, Marian C. Horzinek, Dominique Schols

Article1996

Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1

José A. Esté, K De Vreese, Myriam Witvrouw, Jean‐Claude Schmit, Anne‐Mieke Vandamme, Jozef Anné, Jan Desmyter, Geoffrey Henson, Gary Bridger, De Clercq Erik

Article1989

Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro.

Masanori Baba, Dominique Schols, Hiroshi Nakashima, Rudi Pauwels, G. Parmentier, Dirk Meijer, De Clercq Erik